Basic Information
Blue Lake Biotechnology is a startup focused on developing human vaccines using novel viral vectors. Its goal is to develop PIV5-based vaccines for human diseases, with an initial focus on respiratory syncytial virus, and it has received FDA approval to proceed to Phase I trials.
Blue Lake Biotechnology, Inc.
Georgia,United States of America
less than 15 people
January 01, 2019
admin@bluelakebiotechnology.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios